Clinical Trials Browser

Phase 1/2 × Mesothelioma × osimertinib × Clear all

NCT04665206 2025-10-28

Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasmThoracic

Mesothelioma